<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Fusion Antibodies Ltd from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Fusion Antibodies Ltd news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 04:17:02 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Fusion+Antibodies+Ltd" rel="self" type="application/rss+xml" />

	
<item><title>Research and Markets: Neurology: A Queen Square Textbook</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032668&amp;HITNO=0&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032668&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534758432%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032668&amp;HITNO=0&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032668&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534758432%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>RBC Dain Rauscher:</description></item>
<item><title>Novozymes and Prometic enter into alliance for purification of albumin-fusion proteins</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4018120&amp;HITNO=1&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4018120&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2525485201%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4018120&amp;HITNO=1&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4018120&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2525485201%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Bionity.com:</description></item>
<item><title>Trimeris Reports Fourth Quarter 2009 FUZEON Sales Results</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4016463&amp;HITNO=2&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4016463&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524772827%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4016463&amp;HITNO=2&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4016463&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524772827%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharma Live:</description></item>
<item><title>Novozymes, ProMetic ink agreement for purification of albumin-fusion proteins</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4002792&amp;HITNO=3&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4002792&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2519178436%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4002792&amp;HITNO=3&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4002792&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2519178436%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharmacy Choice:</description></item>
<item><title>Trimeris Reports Fourth Quarter 2009 FUZEON Sales Results</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4002209&amp;HITNO=4&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4002209&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2518785568%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4002209&amp;HITNO=4&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4002209&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2518785568%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Genetic Engineering News:</description></item>
<item><title>Novozymes and ProMetic Enter Into Alliance for Purification of Albumin-Fusion Proteins</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4000016&amp;HITNO=5&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4000016&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2517785739%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4000016&amp;HITNO=5&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4000016&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2517785739%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharmacy Choice:</description></item>
<item><title>Novozymes and ProMetic Enter Into Alliance for Purification of Albumin-Fusion Proteins</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3996888&amp;HITNO=6&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3996888&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2516502737%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3996888&amp;HITNO=6&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3996888&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2516502737%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Yahoo! Canada:</description></item>
<item><title>Trimeris Reports Fourth Quarter 2009 FUZEON Sales Results</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4001661&amp;HITNO=7&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4001661&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2518528591%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4001661&amp;HITNO=7&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4001661&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2518528591%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Genetic Engineering News:</description></item>
<item><title>Compugen Discovers Novel Protein for Treatment of Autoimmune Diseases</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4001714&amp;HITNO=8&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4001714&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2518546252%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4001714&amp;HITNO=8&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4001714&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2518546252%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharma Live:</description></item>
<item><title>Compugen Discovers Novel Protein for Treatment of Autoimmune Diseases</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4000312&amp;HITNO=9&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4000312&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2517959673%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4000312&amp;HITNO=9&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4000312&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2517959673%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Therapeutics Daily:</description></item>
<item><title>Compugen Discovers Novel Protein for Treatment of Autoimmune Diseases</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3997516&amp;HITNO=10&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3997516&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2516731749%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3997516&amp;HITNO=10&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3997516&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2516731749%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Genetic Engineering News:</description></item>
<item><title>Research and Markets: Therapeutic Monoclonal Antibodies: From Bench to Clinic</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3983104&amp;HITNO=11&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3983104&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2507692507%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3983104&amp;HITNO=11&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3983104&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2507692507%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Yahoo! Canada:</description></item>
<item><title>Medical News: Generation Of Fully Human Monoclonal Antibodies Neutralizing Influenza Virus Use Of SPYMEG As A Novel Human Lymphocyte Fusion Partner</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3969209&amp;HITNO=12&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3969209&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2500715433%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3969209&amp;HITNO=12&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3969209&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2500715433%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>BioFind:</description></item>
<item><title>Generation of Fully Human Monoclonal Antibodies Neutralizing Influenza Virus - Use of SPYMEG as a novel human</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3967864&amp;HITNO=13&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3967864&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2499964873%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3967864&amp;HITNO=13&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3967864&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2499964873%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Genetic Engineering News:</description></item>
<item><title>Generation Of Fully Human Monoclonal Antibodies Neutralizing Influenza Virus Use Of SPYMEG As A Novel Human Ly</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3968494&amp;HITNO=14&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3968494&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2500397472%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3968494&amp;HITNO=14&amp;MSIZE=23&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Fusion%20Antibodies%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3968494&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2500397472%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Medical News Today:</description></item>
</channel></rss>